The Higher Plasma Malondialdehyde Concentrations Are Determined by Metabolic Syndrome-Related Glucolipotoxicity

Figure 1

Logistic regression analysis identifying the main predictors for higher plasma MDA concentrations; (a) metabolic syndrome and its components; (b) anthropometry, body composition, and fitness; (c) dietary intake; (d) blood markers. Analyses were adjusted for age, gender, smoking status, medicine use, BMI, and energy intake. Black circles are odds ratio and traces are confidence interval. ^∗𝑃<0.05.

(a)

(b)

(c)

(d)